Justin Kim
Stock Analyst at Oppenheimer
(4.34)
# 1,315
Out of 5,058 analysts
103
Total ratings
49.6%
Success rate
13.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Kim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $110 → $85 | $42.70 | +99.06% | 7 | Sep 24, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $15 → $16 | $4.41 | +262.81% | 4 | Jun 8, 2026 | |
| IMCR Immunocore Holdings | Reiterated: Buy | $85 → $86 | $28.34 | n/a | 10 | May 8, 2025 | |
| CYTK Cytokinetics | Reiterated: Buy | $54 → $96 | $63.43 | n/a | 10 | Feb 28, 2025 | |
| ALDX Aldeyra Therapeutics | Reiterated: Buy | $12 | $0.7904 | n/a | 21 | Oct 3, 2024 | |
| VERA Vera Therapeutics | Reiterated: Buy | $34 | $26.74 | n/a | 1 | Jan 26, 2024 | |
| PHVS Pharvaris | Rated: Buy | $26 | $30.02 | n/a | 8 | Nov 10, 2023 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Hold | n/a | $16.61 | n/a | 28 | Aug 8, 2023 | |
| BCRX BioCryst Pharmaceuticals | Reiterated: Hold | n/a | $8.05 | n/a | 6 | Dec 15, 2022 | |
| ELTX Elicio Therapeutics | Downgraded: Hold | n/a | $1.79 | n/a | 8 | Jun 30, 2022 |
Ionis Pharmaceuticals
Sep 24, 2026
Reiterated: Buy
Price Target: $110 → $85
Current: $42.70
Upside: +99.06%
Zura Bio
Jun 8, 2026
Reiterated: Buy
Price Target: $15 → $16
Current: $4.41
Upside: +262.81%
Immunocore Holdings
May 8, 2025
Reiterated: Buy
Price Target: $85 → $86
Current: $28.34
Upside: n/a
Cytokinetics
Feb 28, 2025
Reiterated: Buy
Price Target: $54 → $96
Current: $63.43
Upside: n/a
Aldeyra Therapeutics
Oct 3, 2024
Reiterated: Buy
Price Target: $12
Current: $0.7904
Upside: n/a
Vera Therapeutics
Jan 26, 2024
Reiterated: Buy
Price Target: $34
Current: $26.74
Upside: n/a
Pharvaris
Nov 10, 2023
Rated: Buy
Price Target: $26
Current: $30.02
Upside: n/a
Aurinia Pharmaceuticals
Aug 8, 2023
Reiterated: Hold
Price Target: n/a
Current: $16.61
Upside: n/a
BioCryst Pharmaceuticals
Dec 15, 2022
Reiterated: Hold
Price Target: n/a
Current: $8.05
Upside: n/a
Elicio Therapeutics
Jun 30, 2022
Downgraded: Hold
Price Target: n/a
Current: $1.79
Upside: n/a